130 related articles for article (PubMed ID: 12032662)
1. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.
Shi W; Teschendorf C; Muzyczka N; Siemann DW
Cancer Gene Ther; 2002 Jun; 9(6):513-21. PubMed ID: 12032662
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
4. [Research of the anti-tumor effect of human endostatin mediated by recombinant adeno-associated virus].
Lu GQ; Zha YY; Wu XB; Yang JG; Zhang XY; Fu M; Liang X; Wu M; Lin C
Ai Zheng; 2002 Dec; 21(12):1314-8. PubMed ID: 12520738
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
[TBL] [Abstract][Full Text] [Related]
6. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer.
Isayeva T; Ren C; Ponnazhagan S
Clin Cancer Res; 2005 Feb; 11(3):1342-7. PubMed ID: 15709207
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.
Lai LJ; Xiao X; Wu JH
J Biomed Sci; 2007 May; 14(3):313-22. PubMed ID: 17373573
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effect of human endostatin mediated by retroviral gene transfer in nude mice.
Wang X; Liu F; Li X; Li J; Xu G
Chin Med J (Engl); 2002 Nov; 115(11):1664-9. PubMed ID: 12609084
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
[TBL] [Abstract][Full Text] [Related]
12. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy.
Nguyen JT; Wu P; Clouse ME; Hlatky L; Terwilliger EF
Cancer Res; 1998 Dec; 58(24):5673-7. PubMed ID: 9865720
[TBL] [Abstract][Full Text] [Related]
14. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery.
Nakashima Y; Yano M; Kobayashi Y; Moriyama S; Sasaki H; Toyama T; Yamashita H; Fukai I; Iwase H; Yamakawa Y; Fujii Y
Gene Ther; 2003 Jan; 10(2):123-30. PubMed ID: 12571641
[TBL] [Abstract][Full Text] [Related]
15. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
[TBL] [Abstract][Full Text] [Related]
16. [Adeno-associated virus-mediated expression of human endostatin and its biological activity in vitro].
Li XH; Li XP; Li G; Liu X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):651-4. PubMed ID: 15958300
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
18. Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice.
Jia S; Zhu F; Li H; He F; Xiu R
Clin Hemorheol Microcirc; 2000; 23(2-4):251-7. PubMed ID: 11321448
[TBL] [Abstract][Full Text] [Related]
19. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
20. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]